Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Lifecare

Less than 1K followers

LIFE

Oslo Børs

Medical Equipment & Services

Health Care

Overview
Investor views

Lifecare is a Norwegian company operating in medical technology. The company specializes in research and development of solutions for diabetes. The microsensors are injected under the skin of the patient's wrist, and also function as a real-time update of the patient's glucose level. In addition, the technology provides an alarm sensor and access to historical data on the patient's glucose level. The company was established in 2006 and is headquartered in Bergen, Norway.

Read more
Market cap
-
Turnover
-
Revenue
6.64M
EBIT %
-1,957.41 %
P/E
-
Dividend yield-%
-
Financial calendar
12.11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Press release31.08.2026, 10.11

DNB Carnegie Access: Lifecare ASA: Agrees to acquire manufacturing capacity in Bergen

Lifecare
Regulatory press release31.08.2026, 07.00

Lifecare ASA acquires 80% of Ocean TuniCell – securing established GMP manufacturing infrastructure in Bergen

Lifecare
Press release19.08.2026, 17.54

DNB Carnegie Access: Lifecare ASA: More durability, less visibility – Q2 review

Lifecare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release19.08.2026, 07.00

LIFE: Lifecare ASA Q2 2026 results

Lifecare
Regulatory press release12.08.2026, 07.00

Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST

Lifecare
Press release12.08.2026, 07.00

Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST

Lifecare
Regulatory press release02.07.2026, 07.00

LIFE: Update on production transfer and longevity programme

Lifecare
Press release02.07.2026, 07.00

LIFE: Update on production transfer and longevity programme

Lifecare
Regulatory press release26.06.2026, 17.30

LIFE: Operational update regarding Lifecare Germany GmbH (i.L)

Lifecare
Regulatory press release22.06.2026, 13.05

Lifecare ASA: Share capital increase registered

Lifecare
Regulatory press release22.06.2026, 07.00

LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation

Lifecare
Press release22.06.2026, 07.00

LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation

Lifecare
Regulatory press release12.06.2026, 17.30

Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue

Lifecare
Regulatory press release12.06.2026, 07.00

Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release11.06.2026, 08.10

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release10.06.2026, 16.11

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release10.06.2026, 07.00

LIFE: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response

Lifecare
Press release10.06.2026, 07.00

Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response

Lifecare
Regulatory press release05.06.2026, 07.00

Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release03.06.2026, 13.15

Lifecare ASA: Mandatory notification of trade

Lifecare